Hienert, Marius
Gryglewski, Gregor
Stamenkovic, Mara
Kasper, Siegfried
Lanzenberger, Rupert
Article History
Received: 11 December 2017
Revised: 17 May 2018
Accepted: 5 June 2018
First Online: 2 August 2018
Conflict of interest
: The authors declare that they have no conflict of interest. G. Gryglewski is recipient of a DOC Fellowship of the Austrian Academy of Sciences at the Medical University of Vienna. R. Lanzenberger received travel grants and/or conference speaker honoraria from Shire, AstraZeneca, Lundbeck A/S, Dr. Willmar Schwabe GmbH, Orphan Pharmaceuticals AG, Janssen-Cilag Pharma GmbH, and Roche Austria GmbH. Siegfried Kasper received grants/research support, consulting fees and/or honoraria within the last 3 years from Angelini, AOP Orphan Pharmaceuticals AG, AstraZeneca, Eli Lilly, Janssen, KRKA-Pharma, Lundbeck, Neuraxpharm, Pfizer, Pierre Fabre, Schwabe and Servier. M. Hienert and M.